AT7867
AT7867 is a potent and selective ATP-competitive inhibitor targeting key AGC kinases, including Akt1/2/3 and p70S6K/PKA. It is widely used in biochemical and cellular research to investigate PI3K/Akt/mTOR signaling pathways in cancer and metabolic studies, with applications in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
857531-00-1
Product Name Alternative
Akt, AT7867, AT-7867, AT 7867, Akt3, Akt2, Akt1, inhibit, Inhibitor, p70 S6K, Protein kinase B, Protein kinase A, Ribosomal S6 Kinase (RSK), S6Kinase, S6K, S6 Kinase, PKB, PKA
Field of Research
Signal Transduction
Purity
99.63% (May vary between batches)
Solubility
DMSO:63 mg/mL (186.47 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble) ; Ethanol:5 mg/mL (14.8 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (2.96 mM)
Smiles
Clc1ccc (cc1) C1 (CCNCC1) c1ccc (cc1) -c1cn[nH]c1
Molecular Formula
C20H20ClN3
Molecular Weight
337.85
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RA0082-01 100 µg
Enoblituzumab (Biosimilar Reference Antibody) (CD276)
Sign In for Pricing
View Details RA0082-02 1 mg
Enoblituzumab (Biosimilar Reference Antibody) (CD276)
Sign In for Pricing
View Details RA0082-03 5 mg
Enoblituzumab (Biosimilar Reference Antibody) (CD276)
Sign In for Pricing
View Details RA0082-04 10 mg
Enoblituzumab (Biosimilar Reference Antibody) (CD276)
Sign In for Pricing
View Details RA0082-05 25 mg
Enoblituzumab (Biosimilar Reference Antibody) (CD276)
Sign In for Pricing
View Details